Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for CANGRELOR
- Effects of Cangrelor on MIcRovAscular Disfunction During Elective Percutaneous CORonary Intervention
- Proximal Internal Carotid Artery Acute Stroke Secondary to Tandem or Local Occlusion Thrombectomy Trial
- Evaluation of Myocardial Reperfusion After Primary PCI in Patients With High Platelet Reactivity Treated by Cangrelor or Not
- Pharmacodynamic and Pharmacokinetic of Switching From Cangrelor to Prasugrel in ACS Patients Undergoing PCI
- REperfusion With P2Y12 Inhibitors in Addition to mEchanical thRombectomy for perFUsion Imaging Selected Acute Stroke patiEnts
- PD and PK Profiles of Switching Between Cangrelor and Ticagrelor Following Ticagrelor Pre-treatment
- Cangrelor in Comatose Survivors of OHCA Undergoing Primary PCI
- Maintenance Of aNtiplatElet Therapy in Patients With Coronary Stenting Undergoing Surgery (MONET BRIDGE)
- Dual Antiplatelet Therapy For Shock Patients With Acute Myocardial Infarction
- Add-on Cangrelor in STEMI-triggered Cardiac Arrest
- Platelet Inhibition With Cangrelor and Crushed Ticagrelor in STEMI
- Cangrelor vs. Ticagrelor for Early Platelet Inhibition in STEMI
- Platelet Inhibition to Target Reperfusion Injury
- Cangrelor in ST-Elevation Myocardial Infarction to Decrease Infarct Size
- Randomized Comparison of Cangrelor, Tirofiban and Prasugrel in Patients With STEMI Referred for Primary PCI.
- Cangrelor Following Ticagrelor Loading vs Ticagrelor Loading Alone in STEMI
- Crushed Ticagrelor Versus Eptifibatide Bolus + Clopidogrel
- Cangrelor Neonatal PK/PD and Safety Study
- The Effect of IV Cangrelor and Oral Ticagrelor Study
- In Vitro Pharmacodynamic Effects of Cangrelor in Ticagrelor Treated Patients
- Cangrelor to Clopidogrel or Prasugrel Transition Study
- Cangrelor Prasugrel Transition Study
- Cangrelor Ticagrelor Transition Study
- A Clinical Trial Comparing Cangrelor to Clopidogrel Standard Therapy in Subjects Who Require Percutaneous Coronary Intervention (PCI) (CHAMPION PHOENIX)
- Aspirin Resistance and Percutaneous Coronary Intervention (PCI)
- Maintenance of Platelet Inhibition With Cangrelor
- Assess the Effect of Cangrelor at the Therapeutic Dose and a Supratherapeutic Dose Level on the QT/QTc Interval in Healthy Volunteers
- Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition.
- A Clinical Trial to Demonstrate the Efficacy of Cangrelor
- Pharmacokinetics/Pharmacodynamics (PK/PD) of Cangrelor
Clinical trials list
click for details